LUPIN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > lupin

Technical Analysis

Technical Strength: 3.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 36.3. According to RSI analysis, lupin is technically weak. 1.0 LUPIN RSI Chart
MACD (?) MACD: -42.7 and Signal Line: -43.3. According to MACD analysis, a bullish crossover just happend and it's a positive signal. 10.0 LUPIN MACD Chart
Simple Moving Average (?) According to simple moving average analysis, lupin is in a strong downtrend. Major resistance levels are 990.125, 1066.47, 1327.9. 0.0 LUPIN Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, lupin is in a strong downtrend. Major resistance levels are 989.0575, 1063.493, 1279.807. 0.0 LUPIN Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.348. 5.0 LUPIN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 1036.5239 and 1073.275. Support level is 917.55. 2.5 LUPIN Fibonacci Retracement Chart
Average True Range (?) ATR: 29.8 NA LUPIN Average True Range Chart
Average Directional Index (?) ADX is 36.5 which means LUPIN is in a trend. NA LUPIN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 23, 2017
Open Price 948.0
High Price 959.7
Low Price 941.0
Close Price 955.85
Absolute Change 11.45
Percentage Change 1.21%
Weekly Change -0.536%
Monthly Change -14.7%
Yearly Change -40.1%
52-week high 1607.95
52-week low 917.55
Corporate Actions
ExDate Purpose
July 24, 2017 AGM/DIV-RS 7.50 PER SHARE
July 21, 2014 AGM/DIV-RS 3/- PER SHARE
February 13, 2014 INT DIV-RS 3/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.473
Confidence in Beta0.0838%
Market Capital Rs. 43030.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 63.72
TTM Price-to-Earnings (P/E) Ratio 15
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 August 2017: Deliverable Quantity:5.08e+05 NA LUPIN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 August 2017: Daily Volatility:0.3477 NA LUPIN Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 August 2017: PCR_OI:0.297 PCR:0.323 NA LUPIN PCR Chart
Option Pain (?) 23 August 2017: Max Pain:980.0 NA LUPIN Option Pain Chart
Premium (?) 23 August 2017 Premium: 1.7 Futures OI:7977200.0 NA LUPIN Premium Chart
Option_MAX_OI (?) 23 August 2017: Price:955.85 Put with maximum OI:1000.0 Call with maximum OI:1100.0 NA LUPIN Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 31, 2017 957.55 7977200.0 6272.0 7205.0 955.85
September 28, 2017 962.0 634400.0 574.0 662.0 955.85
October 26, 2017 967.35 37600.0 5.0 5.0 955.85

Announcements

August 23, 2017 LupinPress Releasen Limited has informed the Exchange regarding a press release dated August 23, 2017, titled "Lupin launches generic Seroquel XR tablets in the US".
August 22, 2017 LupinPress Releasen Limited has informed the Exchange regarding a press release dated August 21, 2017, titled "Lupin receives EIR from US FDA for Aurangabad, April 2017 Inspection".
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 17, 2017 August 02, 2017 InterResultsr alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2017.
May 02, 2017 May 24, 2017 To coResults/Dividendonsider and take on record the audited standalone and consolidated financial results for the year ended March 31, 2017 and recommend dividend if any.
See all Board Meetings

LUPIN is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 926 Rs. 933.5 Rs. 944.7 Rs. 952.2 Rs. 963.4 Rs. 970.9 Rs. 982.1